Ubs Group Ag Essa Pharma Inc. Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Essa Pharma Inc. stock. As of the latest transaction made, Ubs Group Ag holds 12,021 shares of EPIX stock, worth $2,404. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,021

Previous 23,608 49.08%

Holding current value

$2,404

Previous $37,000 45.95%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$1.44 - $1.82 $16,685 - $21,088	-11,587 Reduced 49.08%	12,021 $20,000
Q1 2025 May 13, 2025	SELL	$1.53 - $1.95 $110,169 - $140,411	-72,006 Reduced 75.31%	23,608 $37,000
Q4 2024 Feb 14, 2025	BUY	$1.4 - $6.23 $130,475 - $580,617	93,197 Added 3855.9%	95,614 $171,000
Q3 2024 Nov 14, 2024	BUY	$4.45 - $7.1 $3,791 - $6,049	852 Added 54.44%	2,417 $14,000
Q2 2024 Aug 13, 2024	SELL	$4.63 - $8.42 $9,542 - $17,353	-2,061 Reduced 56.84%	1,565 $8,000
Q1 2024 May 13, 2024	SELL	$6.17 - $10.65 $7,829 - $13,514	-1,269 Reduced 25.92%	3,626 $30,000
Q4 2023 Feb 09, 2024	BUY	$2.74 - $7.35 $12,960 - $34,765	4,730 Added 2866.67%	4,895 $32,000
Q3 2023 Nov 09, 2023	SELL	$2.65 - $3.31 $702 - $877	-265 Reduced 61.63%	165 $0
Q2 2023 Aug 11, 2023	SELL	$2.6 - $3.34 $7,342 - $9,432	-2,824 Reduced 86.79%	430 $1,000
Q1 2023 May 12, 2023	SELL	$2.56 - $3.55 $8,366 - $11,601	-3,268 Reduced 50.11%	3,254 $9,000
Q4 2022 Feb 08, 2023	BUY	$1.5 - $4.82 $9,783 - $31,436	6,522 New	6,522 $16,000
Q2 2022 Aug 10, 2022	SELL	$3.15 - $7.94 $9,106 - $22,954	-2,891 Reduced 9.19%	28,551 $90,000
Q1 2022 May 16, 2022	BUY	$6.18 - $14.44 $2,033 - $4,750	329 Added 1.06%	31,442 $194,000
Q4 2021 Feb 14, 2022	BUY	$7.8 - $14.38 $126,570 - $233,344	16,227 Added 109.01%	31,113 $442,000
Q3 2021 Nov 15, 2021	SELL	$7.76 - $29.37 $334,875 - $1.27 Million	-43,154 Reduced 74.35%	14,886 $119,000
Q2 2021 Aug 13, 2021	BUY	$24.17 - $34.28 $1.38 Million - $1.96 Million	57,172 Added 6586.64%	58,040 $1.66 Million
Q1 2021 May 12, 2021	BUY	$11.61 - $32.08 $5,387 - $14,885	464 Added 114.85%	868 $25,000
Q4 2020 Feb 11, 2021	SELL	$5.47 - $12.1 $12,838 - $28,398	-2,347 Reduced 85.31%	404 $5,000
Q3 2020 Nov 12, 2020	BUY	$6.0 - $7.79 $16,506 - $21,430	2,751 New	2,751 $19,000
Q2 2020 Jul 31, 2020	SELL	$3.71 - $6.2 $6,028 - $10,075	-1,625 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$3.23 - $5.87 $2,948 - $5,359	913 Added 128.23%	1,625 $7,000
Q4 2019 Feb 14, 2020	BUY	$3.05 - $6.0 $2,171 - $4,272	712 New	712 $4,000

Others Institutions Holding EPIX

# of Institutions

Shares Held

29M

Call Options Held

445K

Put Options Held

201K

View Full List

About ESSA Pharma Inc.

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $8.81M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

More about EPIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account